A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia

OBJECTIVE: Assess the efficacy of duloxetine 60/120 mg (N = 162) once daily compared with placebo (N = 168) in the treatment of patients with fibromyalgia, during six months of treatment. METHODS: This was a phase-III, randomized, double-blind, placebo-controlled, parallel-group study assessing the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chappell, Amy S, Bradley, Laurence A, Wiltse, Curtis, Detke, Michael J, D’Souza, Deborah N, Spaeth, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2009
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2840539/
https://ncbi.nlm.nih.gov/pubmed/20428412
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky